Gerald L. Hogue, Director at POINT Biopharma Global Inc. (PNT), bought 3,660 shares at $6.82 ($25K) on 2022-11-25, disclosed to the SEC on 2022-11-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.